-
1
-
-
0025779484
-
Atrial fibrillation as an independent risk factor for stroke: The Framingham study
-
Wolf PA, Abbott RD, Kanne WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham study. Stroke 1991;22:983-988.
-
(1991)
Stroke
, vol.22
, pp. 983-988
-
-
Wolf, P.A.1
Abbott, R.D.2
Kanne, W.B.3
-
2
-
-
0032497292
-
Impact of Atrial Fibrillation on the Risk of Death: The Framingham heart study
-
Benjamin EJ, Wolf PA, D'Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of Atrial Fibrillation on the Risk of Death: the Framingham heart study. Circulation 1998;98:946-952.
-
(1998)
Circulation
, vol.98
, pp. 946-952
-
-
Benjamin, E.J.1
Wolf, P.A.2
D'Agostino, R.B.3
Silbershatz, H.4
Kannel, W.B.5
Levy, D.6
-
3
-
-
79957482449
-
Risk of death and cardiovascular events in initially healthy women with new-onset atrial fibrillation
-
Conen D, Chae CU, Glynn RJ, Tedrow UB, Everett BM, Buring JE, Albert CM. Risk of death and cardiovascular events in initially healthy women with new-onset atrial fibrillation. J Am Med Assoc 2011;305:2080-2087.
-
(2011)
J Am Med Assoc
, vol.305
, pp. 2080-2087
-
-
Conen, D.1
Chae, C.U.2
Glynn, R.J.3
Tedrow, U.B.4
Everett, B.M.5
Buring, J.E.6
Albert, C.M.7
-
4
-
-
0037028022
-
A comparison of rate control and rhythm control in patients with atrial fibrillation
-
Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators
-
Wyse DG, Waldo AL, DiMarco JP, Domanski MJ, Rosenberg Y, Schron EB, Kellen JC, Greene HL, Mickel MC, Dalquist JE, Corley SD, Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2002;347:1825-1833.
-
(2002)
N Engl J Med
, vol.347
, pp. 1825-1833
-
-
Wyse, D.G.1
Waldo, A.L.2
Dimarco, J.P.3
Domanski, M.J.4
Rosenberg, Y.5
Schron, E.B.6
Kellen, J.C.7
Greene, H.L.8
Mickel, M.C.9
Dalquist, J.E.10
Corley, S.D.11
-
5
-
-
0027436528
-
Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure: Results of the Proved trial
-
Uretsky B, Young JB, Shahidi FE, Yellen LG, Harrison MC, Jolly MK. Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure: results of the Proved trial. J Am Coll Cardiol 1993; 22:955-962.
-
(1993)
J Am Coll Cardiol
, vol.22
, pp. 955-962
-
-
Uretsky, B.1
Young, J.B.2
Shahidi, F.E.3
Yellen, L.G.4
Harrison, M.C.5
Jolly, M.K.6
-
6
-
-
3042520870
-
Digoxin in the management of cardiovascular disorders
-
Gheorghiade M, Adams KF, Colucci WS. Digoxin in the management of cardiovascular disorders. Circulation 2004;109:2959-2964.
-
(2004)
Circulation
, vol.109
, pp. 2959-2964
-
-
Gheorghiade, M.1
Adams, K.F.2
Colucci, W.S.3
-
7
-
-
0037453950
-
Association of serum digoxin concentration and outcomes in patients with heart failure
-
Rathore SS, Curtis JP, Wang Y, Bristow MR, Krumholz HM. Association of serum digoxin concentration and outcomes in patients with heart failure. J Am Med Assoc 2003;289:871-878.
-
(2003)
J Am Med Assoc
, vol.289
, pp. 871-878
-
-
Rathore, S.S.1
Curtis, J.P.2
Wang, Y.3
Bristow, M.R.4
Krumholz, H.M.5
-
9
-
-
0027216221
-
Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors
-
RADIANCE Study investigators
-
Packer M, Gheorghiade M, Young JB, Costantini PJ, Adams KF, Cody RJ, Smith LK, Van Voorhees L, Gourley LA, Jolly MK, RADIANCE Study investigators. Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors. N Engl J Med 1993;329:1-7.
-
(1993)
N Engl J Med
, vol.329
, pp. 1-7
-
-
Packer, M.1
Gheorghiade, M.2
Young, J.B.3
Costantini, P.J.4
Adams, K.F.5
Cody, R.J.6
Smith, L.K.7
Van Voorhees, L.8
Gourley, L.A.9
Jolly, M.K.10
-
10
-
-
0031051347
-
The effect of digoxin on mortality and morbidity in patients with heart failure
-
The Digitalis Investigation Group
-
The Digitalis Investigation Group. The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med 1997;336:525-533.
-
(1997)
N Engl J Med
, vol.336
, pp. 525-533
-
-
-
11
-
-
1842434297
-
Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) study
-
Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators
-
Wyse DG, Waldo AL, DiMarco JP, Domanski MJ, Rosenberg Y, Schron EB, Kellen JC, Greene HL, Mickel MC, Dalquist JE, Corley SD, Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators. Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) study. Circulation 2004;109:1509-1513.
-
(2004)
Circulation
, vol.109
, pp. 1509-1513
-
-
Wyse, D.G.1
Waldo, A.L.2
Dimarco, J.P.3
Domanski, M.J.4
Rosenberg, Y.5
Schron, E.B.6
Kellen, J.C.7
Greene, H.L.8
Mickel, M.C.9
Dalquist, J.E.10
Corley, S.D.11
-
12
-
-
34548544807
-
RIKS-HIA group. Digoxin and mortality in atrial fibrillation: A prospective cohort study
-
Hallberg P, Lindback J, Lindahl B, Stenestrand U, Melhus H, RIKS-HIA group. Digoxin and mortality in atrial fibrillation: a prospective cohort study. Eur J Clin Pharmacol 2007;63:1201-1202.
-
(2007)
Eur J Clin Pharmacol
, vol.63
, pp. 1201-1202
-
-
Hallberg, P.1
Lindback, J.2
Lindahl, B.3
Stenestrand, U.4
Melhus, H.5
-
13
-
-
80054028237
-
Is there an association between external cardioversions and long term mortality and morbidity - Insights from the AFFIRM study
-
Elayi CS, Whitbeck MG, Charnigo R, Shah J, Macaulay TE, Morales G, Gurley JC, Kakavand B, Thal S, Ching CK, Khaykin Y, Verma A, Barrett C, Bai R, Di Biase L, Patwardhan A, Moliterno DJ, Natale A. Is there an association between external cardioversions and long term mortality and morbidity - insights from the AFFIRM study. Circ Arrhythm Electrophysiol 2011;4:465-469.
-
(2011)
Circ Arrhythm Electrophysiol
, vol.4
, pp. 465-469
-
-
Elayi, C.S.1
Whitbeck, M.G.2
Charnigo, R.3
Shah, J.4
MacAulay, T.E.5
Morales, G.6
Gurley, J.C.7
Kakavand, B.8
Thal, S.9
Ching, C.K.10
Khaykin, Y.11
Verma, A.12
Barrett, C.13
Bai, R.14
Di Biase, L.15
Patwardhan, A.16
Moliterno, D.J.17
Natale, A.18
-
14
-
-
13944276448
-
The effect of gender on outcome in digitalis-treated heart failure patients
-
Domanski M, Fleg J, Bristow M, Knox S. The effect of gender on outcome in digitalis-treated heart failure patients. J Card Fail 2005;11:83-86.
-
(2005)
J Card Fail
, vol.11
, pp. 83-86
-
-
Domanski, M.1
Fleg, J.2
Bristow, M.3
Knox, S.4
-
15
-
-
77957053929
-
Digoxin use and heart failure outcomes: Results from the Valsartan Heart Failure Trial (Val-HeFT)
-
Butler J, Anand IS, Kuskowski MA, Rector T, Carson P, Cohn JN. Digoxin use and heart failure outcomes: results from the Valsartan Heart Failure Trial (Val-HeFT). Congest Heart Fail 2010;16:191-195.
-
(2010)
Congest Heart Fail
, vol.16
, pp. 191-195
-
-
Butler, J.1
Anand, I.S.2
Kuskowski, M.A.3
Rector, T.4
Carson, P.5
Cohn, J.N.6
-
16
-
-
0000564018
-
An account of the foxglove and some of its medical uses with practical remarks on dropsy and other diseases
-
Willins FA, Keys TE (eds). New York, NY: Henry Schuman, Dover Publications
-
WitheringW. An account of the foxglove and some of its medical uses, with practical remarks on dropsy, and other diseases. In: Willins FA, Keys TE (eds). Classics of Cardiology. Vol. 1. New York, NY: Henry Schuman, Dover Publications; 1941:231-252.
-
(1941)
Classics of Cardiology
, vol.1
, pp. 231-252
-
-
Withering, W.1
-
17
-
-
33745161093
-
Contemporary use of digoxin in the management of cardiovascular disorders
-
Gheorghiade M, Van Veldhuisen DJ, Colucci WS. Contemporary use of digoxin in the management of cardiovascular disorders. Circulation 2006;113:2556-2564.
-
(2006)
Circulation
, vol.113
, pp. 2556-2564
-
-
Gheorghiade, M.1
Van Veldhuisen, D.J.2
Colucci, W.S.3
-
18
-
-
45549089895
-
Rhythm control versus rate control for atrial fibrillation and heart failure
-
Atrial Fibrillation and Congestive Heart Failure Investigators
-
Roy D, Talajic M, Nattel S, Wyse GD, Dorian P, Lee KL, Kerry L, Bourassa MG, Arnold JMO, Buxton AE, Camm JA, Connolly SJ, Dubuc M, Ducharme A, Guerra PG, Hohnloser SH, Lambert J, Le Heuzey JY, O'Hara G, Pedersen OD, Rouleau JL, Singh BN, Stevenson LW, Stevenson WG, Thibault B, Waldo AL, Atrial Fibrillation and Congestive Heart Failure Investigators. Rhythm control versus rate control for atrial fibrillation and heart failure. N Engl J Med 2008; 358:2667-2677.
-
(2008)
N Engl J Med
, vol.358
, pp. 2667-2677
-
-
Roy, D.1
Talajic, M.2
Nattel, S.3
Wyse, G.D.4
Dorian, P.5
Lee, K.L.6
Kerry, L.7
Bourassa, M.G.8
Jmo, A.9
Buxton, A.E.10
Camm, J.A.11
Connolly, S.J.12
Dubuc, M.13
Ducharme, A.14
Guerra, P.G.15
Hohnloser, S.H.16
Lambert, J.17
Le Heuzey, J.Y.18
O'Hara, G.19
Pedersen, O.D.20
Rouleau, J.L.21
Singh, B.N.22
Stevenson, L.W.23
Stevenson, W.G.24
Thibault, B.25
Waldo, A.L.26
more..
-
19
-
-
3142776467
-
Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol or Metoprolol European Trial (COMET): Randomised controlled trial
-
Carvedilol Or Metoprolol European Trial Investigators.
-
Poole-Wilson PA, Swedberg K, Cleland JG, Di Lenarda A, Hanrath P, Komajda M, Lubsen J, Lutiger B, Metra M, Remme WJ, Torp-Pedersen C, Scherhag A, Skene A, Carvedilol Or Metoprolol European Trial Investigators. Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial. Lancet 2003;362:9377.
-
(2003)
Lancet
, vol.362
, pp. 9377
-
-
Poole-Wilson, P.A.1
Swedberg, K.2
Cleland, J.G.3
Di Lenarda, A.4
Hanrath, P.5
Komajda, M.6
Lubsen, J.7
Lutiger, B.8
Metra, M.9
Remme, W.J.10
Torp-Pedersen, C.11
Scherhag, A.12
Skene, A.13
-
20
-
-
79952398794
-
Irbesartan in patients with atrial fibrillation
-
The ACTIVE I Investigators.
-
The ACTIVE I Investigators. Irbesartan in patients with atrial fibrillation. N Engl J Med 2011;364:928-938.
-
(2011)
N Engl J Med
, vol.364
, pp. 928-938
-
-
-
21
-
-
11144356188
-
The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study: Approaches to control rate in atrial fibrillation
-
The AFFIRM Investigators
-
Brodsky MA, Greene HL, The AFFIRM Investigators. The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study: approaches to control rate in atrial fibrillation. J Am Coll Cardiol 2004;43:1201-1208.
-
(2004)
J Am Coll Cardiol
, vol.43
, pp. 1201-1208
-
-
Brodsky, M.A.1
Greene, H.L.2
-
22
-
-
77951033991
-
Lenient versus strict rate control in patients with atrial fibrillation
-
the Race II Investigators
-
Van Gelder IC, Groenveld HF, Crijns HJ, Tuininga YS, Tijssen JG, the Race II Investigators. Lenient versus strict rate control in patients with atrial fibrillation. N Engl J Med 2010;362:1363-1373.
-
(2010)
N Engl J Med
, vol.362
, pp. 1363-1373
-
-
Van Gelder, I.C.1
Groenveld, H.F.2
Crijns, H.J.3
Tuininga, Y.S.4
Tijssen, J.G.5
-
23
-
-
0037028033
-
A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation
-
Rate Control versus Electrical Cardioversion for Persistent Atrial Fibrillation Study Group
-
Van Gelder IC, Hagens VE, Bosker HA, Kingma JH, Kamp O, Kingma T, Said SA, Darmanata JI, Timmermans AJ, Tijssen JG, Crijns HJ, Rate Control versus Electrical Cardioversion for Persistent Atrial Fibrillation Study Group. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med 2002;347:1834-1840.
-
(2002)
N Engl J Med
, vol.347
, pp. 1834-1840
-
-
Van Gelder, I.C.1
Hagens, V.E.2
Bosker, H.A.3
Kingma, J.H.4
Kamp, O.5
Kingma, T.6
Said, S.A.7
Darmanata, J.I.8
Timmermans, A.J.9
Tijssen, J.G.10
Crijns, H.J.11
-
24
-
-
0026557743
-
Optimal heart rate control for patients with chronic atrial fibrillation: Are pharmacologic choices truly changing?
-
Zarowitz BJ, Gheorghiade M. Optimal heart rate control for patients with chronic atrial fibrillation: are pharmacologic choices truly changing? Am Heart J 1992;123: 1401-1403.
-
(1992)
Am Heart J
, vol.123
, pp. 1401-1403
-
-
Zarowitz, B.J.1
Gheorghiade, M.2
-
25
-
-
0036224231
-
Digoxin: Current use and approach to toxicity
-
Eichhorn EJ, Gheorghiade M. Digoxin: current use and approach to toxicity. Prog Cardiovasc Dis 2002;44:251-266.
-
(2002)
Prog Cardiovasc Dis
, vol.44
, pp. 251-266
-
-
Eichhorn, E.J.1
Gheorghiade, M.2
-
26
-
-
58149458265
-
Comparison of beta blocker and digoxin alone and in combination for management of patients with atrial fibrillation and heart failure
-
Fauchier L, Grimard C, Pierre B, Nonin E, Gorin L, Rauzy B, Cosnay P, Babuty D, Charbonnier B. Comparison of beta blocker and digoxin alone and in combination for management of patients with atrial fibrillation and heart failure. Am J Cardiol 2009;103:248-254.
-
(2009)
Am J Cardiol
, vol.103
, pp. 248-254
-
-
Fauchier, L.1
Grimard, C.2
Pierre, B.3
Nonin, E.4
Gorin, L.5
Rauzy, B.6
Cosnay, P.7
Babuty, D.8
Charbonnier, B.9
-
27
-
-
84860618674
-
Should we SHIFT our thinking about digoxin? Observations on ivabradine and heart rate reduction in heart failure
-
Castagno D, Petrie MC, Claggett B, McMurray J. Should we SHIFT our thinking about digoxin? Observations on ivabradine and heart rate reduction in heart failure. Eur Heart J 2012;33:1137-1141.
-
(2012)
Eur Heart J
, vol.33
, pp. 1137-1141
-
-
Castagno, D.1
Petrie, M.C.2
Claggett, B.3
McMurray, J.4
-
28
-
-
0026082661
-
Poisonings in laboratory personnel and health care professionals
-
Binder L, Fredrickson L. Poisonings in laboratory personnel and health care professionals. Am J Emerg Med 1991;9:11-15.
-
(1991)
Am J Emerg Med
, vol.9
, pp. 11-15
-
-
Binder, L.1
Fredrickson, L.2
-
29
-
-
4243091738
-
Association between the number of coadministered P-glycoprotein inhibitors and serum digoxin levels in patients on therapeutic drug monitoring
-
Englund G, Hallberg P, Artursson P, Michae-lsson K, Melhus H. Association between the number of coadministered P-glycoprotein inhibitors and serum digoxin levels in patients on therapeutic drug monitoring. BMC Med 2004;2:8.
-
(2004)
BMC Med
, vol.2
, pp. 8
-
-
Englund, G.1
Hallberg, P.2
Artursson, P.3
Michaelsson, K.4
Melhus, H.5
-
30
-
-
84855163167
-
Dronedarone in high-risk permanent atrial fibrillation
-
PALLAS Investigators
-
Connolly SJ, Camm AJ, Halperin JL, Joyner C, Alings M, Amerena J, Atar D, Avezum Á, Blomstro?m P, Borggrefe M, Budaj A, Chen SA, Ching CK, Commerford P, Dans A, Davy JM, Delacre'taz E, Di Pasquale G, Diaz R, Dorian P, Flaker G, Golitsyn S, Gonzalez-Hermosillo A, Granger CB, Heidbu?chel H, Kautzner J, Kim JS, Lanas F, Lewis BS, Merino JL, Morillo C, Murin J, Narasimhan C, Paolasso E, Parkhomenko A, Peters NS, Sim KH, Stiles MK, Tanomsup S, Toivonen L, Tomcsa'nyi J, Torp-Pedersen C, Tse HF, Vardas P, Vinereanu D, Xavier D, Zhu J, Zhu JR, Baret-Cormel L, Weinling E, Staiger C, Yusuf S, Chrolavicius S, Afzal R, Hohnloser SH, PALLAS Investigators. Dronedarone in high-risk permanent atrial fibrillation. N Engl J Med 2011;365: 2268-2276.
-
(2011)
N Engl J Med
, vol.365
, pp. 2268-2276
-
-
Connolly, S.J.1
Camm, A.J.2
Halperin, J.L.3
Joyner, C.4
Alings, M.5
Amerena, J.6
Atar, D.7
Avezum, Á.8
Blomstrom, P.9
Borggrefe, M.10
Budaj, A.11
Chen, S.A.12
Ching, C.K.13
Commerford, P.14
Dans, A.15
Davy, J.M.16
Delacre'Taz, E.17
Di Pasquale, G.18
Diaz, R.19
Dorian, P.20
Flaker, G.21
Golitsyn, S.22
Gonzalez-Hermosillo, A.23
Granger, C.B.24
Heidbuchel, H.25
Kautzner, J.26
Kim, J.S.27
Lanas, F.28
Lewis, B.S.29
Merino, J.L.30
Morillo, C.31
Murin, J.32
Narasimhan, C.33
Paolasso, E.34
Parkhomenko, A.35
Peters, N.S.36
Sim, K.H.37
Stiles, M.K.38
Tanomsup, S.39
Toivonen, L.40
Tomcsa'Nyi, J.41
Torp-Pedersen, C.42
Tse, H.F.43
Vardas, P.44
Vinereanu, D.45
Xavier, D.46
Zhu, J.47
Zhu, J.R.48
Baret-Cormel, L.49
Weinling, E.50
Staiger, C.51
Yusuf, S.52
Chrolavicius, S.53
Afzal, R.54
Hohnloser, S.H.55
more..
-
31
-
-
84855167114
-
Dronedarone in atrial fibrillation - Jekyll and Hyde?
-
Nattel S. Dronedarone in atrial fibrillation - Jekyll and Hyde? N Engl J Med 2011; 365:2321-2322.
-
(2011)
N Engl J Med
, vol.365
, pp. 2321-2322
-
-
Nattel, S.1
-
32
-
-
30344472115
-
Digoxin and reduction in mortality and hospitalization in heart failure: A comprehensive post hoc analysis of the DIG trial
-
Ahmed A, Rich MW, Love TE, Lloyd-Jones DM, Aban IB, Colucci WS, Adams KF, Gheorghiade M. Digoxin and reduction in mortality and hospitalization in heart failure: a comprehensive post hoc analysis of the DIG trial. Eur Heart J 2006;27: 178-186.
-
(2006)
Eur Heart J
, vol.27
, pp. 178-186
-
-
Ahmed, A.1
Rich, M.W.2
Love, T.E.3
Lloyd-Jones, D.M.4
Aban, I.B.5
Colucci, W.S.6
Adams, K.F.7
Gheorghiade, M.8
-
33
-
-
0030994095
-
Does digoxin provide additional hemodynamic and autonomic benefit at higher doses in patients with mild to moderate heart failure and normal sinus rhythm?
-
Slatton ML, Irani WN, Hall SA. Does digoxin provide additional hemodynamic and autonomic benefit at higher doses in patients with mild to moderate heart failure and normal sinus rhythm? J Am Coll Cardiol 1997;29:1206-1213.
-
(1997)
J Am Coll Cardiol
, vol.29
, pp. 1206-1213
-
-
Slatton, M.L.1
Irani, W.N.2
Hall, S.A.3
-
34
-
-
0025936181
-
Digoxin: A neurohormonal modulator in heart failure?
-
Gheorghiade M, Ferguson D. Digoxin: a neurohormonal modulator in heart failure? Circulation 1991;84:2181-2186.
-
(1991)
Circulation
, vol.84
, pp. 2181-2186
-
-
Gheorghiade, M.1
Ferguson, D.2
-
35
-
-
0024402581
-
Sympathoinhibitory responses to digitalis glycosides in heart failure patients: Direct evidence from sympathetic neural recordings
-
Ferguson DW, Berg WJ, Sanders JS, Roach PJ, Kempf JS, Kienzle MG. Sympathoinhibitory responses to digitalis glycosides in heart failure patients: direct evidence from sympathetic neural recordings. Circulation 1989;80:65-77.
-
(1989)
Circulation
, vol.80
, pp. 65-77
-
-
Ferguson, D.W.1
Berg, W.J.2
Sanders, J.S.3
Roach, P.J.4
Kempf, J.S.5
Kienzle, M.G.6
-
36
-
-
0037139245
-
Clinical benefits of low serum digoxin concentrations in heart failure
-
Adams KF Jr, Gheorghiade M, Uretsky BF, Patterson JH, Schwartz TA, Young JB. Clinical benefits of low serum digoxin concentrations in heart failure. J Am Coll Cardiol 2002;39:946-953.
-
(2002)
J Am Coll Cardiol
, vol.39
, pp. 946-953
-
-
Adams Jr., K.F.1
Gheorghiade, M.2
Uretsky, B.F.3
Patterson, J.H.4
Schwartz, T.A.5
Young, J.B.6
-
37
-
-
58149461718
-
Effectiveness of digoxin in reducing one-year mortality in chronic heart failure in the digitalis investigation group trial
-
Ahmed A, Waagstein F, Pitt B, White M, Zannad F, Young JB, Rahimtoola SH. Effectiveness of digoxin in reducing one-year mortality in chronic heart failure in the digitalis investigation group trial. Am J Cardiol 2009;103:82-87.
-
(2009)
Am J Cardiol
, vol.103
, pp. 82-87
-
-
Ahmed, A.1
Waagstein, F.2
Pitt, B.3
White, M.4
Zannad, F.5
Young, J.B.6
Rahimtoola, S.H.7
-
38
-
-
0015806759
-
The inotropic effects of digoxin in hyperkalemia: Relation to (Na+, K+)-ATPase inhibition in the intact animal
-
Goldman RH, Coltart J, Friedman JP, Nola GT, Berke DK, Schweizer E, Harrison DC. The inotropic effects of digoxin in hyperkalemia: relation to (Na+, K+)-ATPase inhibition in the intact animal. Circulation 1973;48:830-838.
-
(1973)
Circulation
, vol.48
, pp. 830-838
-
-
Goldman, R.H.1
Coltart, J.2
Friedman, J.P.3
Nola, G.T.4
Berke, D.K.5
Schweizer, E.6
Harrison, D.C.7
-
39
-
-
77955468070
-
Pathogenesis of sudden unexpected death in a clinical trial of patients with myocardial infarction and left ventricular dysfunction, heart failure, or both
-
VALIANT Investigators
-
Pouleur AC, Barkoudah E, Uno H, Skali H, Finn PV, Zelenkofske SL, Belenkov YN, Mareev V, Velazquez EJ, Rouleau JL, Maggioni AP, Køber L, Califf RM, McMurray JJ, Pfeffer MA, Solomon SD, VALIANT Investigators. Pathogenesis of sudden unexpected death in a clinical trial of patients with myocardial infarction and left ventricular dysfunction, heart failure, or both. Circulation 2010;122:597-602.
-
(2010)
Circulation
, vol.122
, pp. 597-602
-
-
Pouleur, A.C.1
Barkoudah, E.2
Uno, H.3
Skali, H.4
Finn, P.V.5
Zelenkofske, S.L.6
Belenkov, Y.N.7
Mareev, V.8
Velazquez, E.J.9
Rouleau, J.L.10
Maggioni, A.P.11
Køber, L.12
Califf, R.M.13
McMurray, J.J.14
Pfeffer, M.A.15
Solomon, S.D.16
-
40
-
-
11144358231
-
Analysis of causespecific mortality in the atrial fibrillation follow-up investigation of rhythm management (AFFIRM) study
-
Steinberg JS, Sadaniantz A, Kron J, Krahn A, Denny DM, Daubert J, Campbell WB, Havranek E, Murray K, Olshansky B, O'Neill G, Sami M, Schmidt S, Storm R, Zabalgoitia M, Miller J, Chandler M, Nasco EM, Greene HL. Analysis of causespecific mortality in the atrial fibrillation follow-up investigation of rhythm management (AFFIRM) study. Circulation 2004;109:1973-1980.
-
(2004)
Circulation
, vol.109
, pp. 1973-1980
-
-
Steinberg, J.S.1
Sadaniantz, A.2
Kron, J.3
Krahn, A.4
Denny, D.M.5
Daubert, J.6
Campbell, W.B.7
Havranek, E.8
Murray, K.9
Olshansky, B.10
O'Neill, G.11
Sami, M.12
Schmidt, S.13
Storm, R.14
Zabalgoitia, M.15
Miller, J.16
Chandler, M.17
Nasco, E.M.18
Greene, H.L.19
-
41
-
-
0037206368
-
Sex-based differences in the effect of digoxin for the treatment of heart failure
-
Rathmore SS,Wang Y, Krumholz M. Sex-based differences in the effect of digoxin for the treatment of heart failure. N Engl J Med 2002;347:1403-1411.
-
(2002)
N Engl J Med
, vol.347
, pp. 1403-1411
-
-
Rathmore, S.S.1
Wang, Y.2
Krumholz, M.3
|